TNFRSF9 and neoplasm: Although it is now clear that anti-4-1BB antibodies are excellent therapeutic agents in inhibiting tumor growth in various in vivo mouse models, a major limitation is that a strategy is still needed to safely translate anti-4-1BB immunotherapy into the clinic with a manageable toxicity profile71,72.